How common are the side effects of artesunate?

What side effects show up most often with artesunate?

Artesunate is used to treat severe malaria and produces side effects in many patients. Neurologic symptoms such as dizziness, ringing in the ears, and confusion occur frequently, along with gastrointestinal complaints like nausea, vomiting, and reduced appetite. Cardiac effects, including ECG changes and QT prolongation, also appear regularly.

Why do these side effects occur?

Artesunate breaks down into dihydroartemisinin, its active metabolite. The compound interferes with parasite mitochondria and calcium homeostasis in infected erythrocytes, but the same mechanism can affect normal human cells in the nervous system and gastrointestinal tract. Laboratory tests show delayed hemolysis after treatment finishes, especially when patients have high initial parasite loads.

What happens if side effects persist or worsen?

Patients who keep experiencing dizziness or gastrointestinal upset after treatment should contact a clinician. Delayed hemolysis can require transfusion in severe cases. Prolonged QT intervals on ECG require immediate medical attention because they can lead to dangerous arrhythmias.

Can side effects appear weeks after treatment ends?

Yes. Delayed hemolysis often begins two to three weeks after the finish of treatment. The process involves pitting of parasitized erythrocytes by the spleen, leaving non-infected erythrocytes that later disintegrate. Studies report rates as high as 20–30 percent in non-immune travelers returning from areas where malaria is endemic.

How does artesunate compare with quinine and artemether-lumefantrine?

Quinine produces more frequent cinchonism—tinnitus, vertigo, and visual disturbances—while artesunate shows lower rates of these complaints. Compared with artemether-lumefantrine, artesunate used intravenously for severe malaria has higher immediate risk of neurologic and cardiac monitoring needs.